1. Home
  2. JD vs RMD Comparison

JD vs RMD Comparison

Compare JD & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JD.com Inc.

JD

JD.com Inc.

N/A

Current Price

$29.18

Market Cap

36.6B

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

N/A

Current Price

$233.01

Market Cap

33.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JD
RMD
Founded
2006
1989
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.6B
33.6B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
JD
RMD
Price
$29.18
$233.01
Analyst Decision
Strong Buy
Buy
Analyst Count
35
20
Target Price
$38.93
★ $265.11
AVG Volume (30 Days)
★ 8.0M
1.3M
Earning Date
11-17-2026
10-29-2026
Dividend Yield
★ 3.49%
1.10%
EPS Growth
N/A
★ 9.67
EPS
N/A
★ 2.92
Revenue
N/A
★ $2,957,013,000.00
Revenue This Year
$2.90
$3.23
Revenue Next Year
$5.50
$6.40
P/E Ratio
★ $9.17
$82.37
Revenue Growth
N/A
★ 13.44
52 Week Low
$24.51
$180.27
52 Week High
$34.30
$277.67

Technical Indicators

Market Signals
Indicator
JD
RMD
Relative Strength Index (RSI) 73.23 46.51
Support Level $28.25 $217.41
Resistance Level $29.95 $236.06
Average True Range (ATR) 0.51 7.64
MACD 0.41 -2.01
Stochastic Oscillator 96.96 33.47

Price Performance

Historical Comparison
JD
RMD

About JD JD.com Inc.

JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: